MayTech Global Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

MayTech Global Investments’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4	Closed	-$2.89K	–	52
2022 Q4	$2.89K	Buy	+4	New	+$2.95K	﹤0.01%	62
2022 Q3	–	Sell	-4	Closed	-$2K	–	62
2022 Q2	$2K	Hold	4	–	–	﹤0.01%	71
2022 Q1	$3K	Hold	4	–	–	﹤0.01%	76
2021 Q4	$3K	Hold	4	–	–	﹤0.01%	87
2021 Q3	$2K	Hold	4	–	–	﹤0.01%	68
2021 Q2	$2K	Hold	4	–	–	﹤0.01%	66
2021 Q1	$2K	Hold	4	–	–	﹤0.01%	58
2020 Q4	$2K	Hold	4	–	–	﹤0.01%	57
2020 Q3	$2K	Sell	4 -61	-94%	-$37K	﹤0.01%	53
2020 Q2	$41K	Hold	65	–	–	0.01%	43
2020 Q1	$32K	Hold	65	–	–	0.01%	41
2019 Q4	$24K	Hold	65	–	–	0.01%	43
2019 Q3	$18K	Hold	65	–	–	0.01%	39
2019 Q2	$20K	Hold	65	–	–	0.01%	40
2019 Q1	$27K	Hold	65	–	–	0.01%	38
2018 Q4	$24K	Buy	65 +61	+1,525%	+$22.3K	0.02%	37
2018 Q3	$2K	Hold	4	–	–	﹤0.01%	43
2018 Q2	$1K	Sell	4 -17,855	-100%	-$5.58M	﹤0.01%	44
2018 Q1	$6.15M	Buy	17,859 +8,635	+94%	+$3M	3.59%	15
2017 Q4	$3.47M	Buy	+9,224	New	+$3.74M	2.28%	18

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MayTech Global Investments's REGN Position: Q1 2023 in Review

MayTech Global Investments sold out of Regeneron Pharmaceuticals (REGN) in Q1 2023, closing a stake of 4 shares — an estimated $2.89K sold.

MayTech Global Investments first reported a position in REGN in Q4 2017 and held it in 20 quarters. The position peaked at $6.15M in Q1 2018. 1,193 funds tracked by Wall St. Rank hold REGN as of Q1 2023.

MayTech Global Investments reported no remaining Regeneron Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
MayTech Global Investments sold 4 Regeneron Pharmaceuticals shares in Q1 2023, an estimated $2.89K.
MayTech Global Investments first reported a position in Regeneron Pharmaceuticals in Q4 2017 and held it in 20 quarters.
MayTech Global Investments's Regeneron Pharmaceuticals position peaked at $6.15M in Q1 2018.
1,193 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2023.

Based on MayTech Global Investments's 13F filing for Q1 2023, filed 11 May 2023.